Superoxide Dismutase1 Levels in North Indian Population with Age-Related Macular Degeneration
Table 1
Clinical and demographic details of subjects.
Variables
AMD
Controls
Total
115
61
Wet AMD
84 (73.04%)
—
Dry AMD
31 (26.96%)
—
Minimal classic
7 (11.9%)
—
Predominant classic
16 (27.1%)
—
Occult
36 (61.0%)
—
Avastin treated
55 (65.5%)
—
Not treated with Avastin
29 (34.5%)
—
Duration of disease¥
23 ± 2.6 (M)
—
Smokers
50 (43.5%)
11 (20%)
Nonsmokers
65 (56.5%)
44 (80%)
Alcoholic
37 (32.2%)
17 (30.9%)
Nonalcoholic
78 (67.8%)
38 (69.1%)
Vegetarian
61 (53%)
31 (56.4%)
Nonvegetarian
54 (47%)
24 (43.6%)
Hypertension
52 (45.2%)
10 (16.4%)
Nonhypertensive
61 (53%)
45 (73.8%)
Heart disease
16 (13.9%)
—
No heart disease
60 (52.2%)
55 (100%)
Age
64.97 ± 7.1
60.38 ± 13.2
Male
75 (65.2%)
40 (65.6%)
Female
40 (34.8%)
21 (34.4%)
AMD: age-related macular degeneration; M: months; Age: age of onset. Values are mean ± SD or percentage, Duration of disease is the interval between appearance of the first symptom of AMD and collection of sample. AMD subjects were asked to provide all clinical and demographic details at the age of disease onset.
